Trial
NCT03865563
Selective Transvenous Chemoembolization of Primary Pancreatic Tumors
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
—
Condition
Pancreatic Adenocarcinoma
Intervention
Retrograde venous infusion of gemcitabine/lipiodol
Why stopped
We need to make significant adjustments to proposed drug and its delivery method
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-27